Literature DB >> 30678628

The Role of Neuropeptide Y and Peptide YY in the Development of Obesity via Gut-brain Axis.

Yi Wu1, Hengxun He1, Zhibin Cheng2, Yueyu Bai3,4, Xi Ma1.   

Abstract

Obesity is one of the main challenges of public health in the 21st century. Obesity can induce a series of chronic metabolic diseases, such as diabetes, dyslipidemia, hypertension and nonalcoholic fatty liver, which seriously affect human health. Gut-brain axis, the two-direction pathway formed between enteric nervous system and central nervous system, plays a vital role in the occurrence and development of obesity. Gastrointestinal signals are projected through the gut-brain axis to nervous system, and respond to various gastrointestinal stimulation. The central nervous system regulates visceral activity through the gut-brain axis. Brain-gut peptides have important regulatory roles in the gut-brain axis. The brain-gut peptides of the gastrointestinal system and the nervous system regulate the gastrointestinal movement, feeling, secretion, absorption and other complex functions through endocrine, neurosecretion and paracrine to secrete peptides. Both neuropeptide Y and peptide YY belong to the pancreatic polypeptide family and are important brain-gut peptides. Neuropeptide Y and peptide YY have functions that are closely related to appetite regulation and obesity formation. This review describes the role of the gutbrain axis in regulating appetite and maintaining energy balance, and the functions of brain-gut peptides neuropeptide Y and peptide YY in obesity. The relationship between NPY and PYY and the interaction between the NPY-PYY signaling with the gut microbiota are also described in this review. Copyright© Bentham Science Publishers; For any queries, please email at epub@benthamscience.net.

Entities:  

Keywords:  Gut-brain axis; brain-gut peptide; gut microbiota; neuropeptide Y; obesity; peptide YY.

Year:  2019        PMID: 30678628     DOI: 10.2174/1389203720666190125105401

Source DB:  PubMed          Journal:  Curr Protein Pept Sci        ISSN: 1389-2037            Impact factor:   3.272


  8 in total

1.  Emerging concepts and opportunities for endocrine disruptor screening of the non-EATS modalities.

Authors:  Christopher J Martyniuk; Rubén Martínez; Laia Navarro-Martín; Jorke H Kamstra; Adam Schwendt; Stéphane Reynaud; Lorraine Chalifour
Journal:  Environ Res       Date:  2021-08-19       Impact factor: 6.498

Review 2.  Prenatal Effects of Nicotine on Obesity Risks: A Narrative Review.

Authors:  Olivia White; Nicole Roeder; Kenneth Blum; Rina D Eiden; Panayotis K Thanos
Journal:  Int J Environ Res Public Health       Date:  2022-08-02       Impact factor: 4.614

3.  Brain Natriuretic Peptide (BNP) Affects Growth and Stress Tolerance of Representatives of the Human Microbiome, Micrococcus luteus C01 and Alcaligenes faecalis DOS7.

Authors:  Nataliya Loiko; Oleg Kanunnikov; Andrei Gannesen; Vladislav Kovalenko; Anastasia Vishnyakova; Vladimir Axelrod; Yuriy Litti
Journal:  Biology (Basel)       Date:  2022-06-29

Review 4.  The molecular signaling of exercise and obesity in the microbiota-gut-brain axis.

Authors:  Filipe M Ribeiro; Maycon A Silva; Victória Lyssa; Gabriel Marques; Henny K Lima; Octavio L Franco; Bernardo Petriz
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-28       Impact factor: 6.055

5.  Intervention Effects of Okra Extract on Brain-Gut Peptides and Intestinal Microorganisms in Sleep Deprivation Rats.

Authors:  Jingru Wu; Mingxue Cao; Ming Hu; Yu Gong; Jianming Xue; Yilin Yang; Hairui Zhou
Journal:  Evid Based Complement Alternat Med       Date:  2022-09-24       Impact factor: 2.650

6.  Gut Microbiota Restores Central Neuropeptide Deficits in Germ-Free Mice.

Authors:  Sevag Hamamah; Mihai Covasa
Journal:  Int J Mol Sci       Date:  2022-10-04       Impact factor: 6.208

Review 7.  Gut microbiota in obesity.

Authors:  Bing-Nan Liu; Xiao-Tong Liu; Zi-Han Liang; Ji-Hui Wang
Journal:  World J Gastroenterol       Date:  2021-07-07       Impact factor: 5.742

8.  Neuropeptide Y as a risk factor for cardiorenal disease and cognitive dysfunction in chronic kidney disease: translational opportunities and challenges.

Authors:  Carmine Zoccali; Alberto Ortiz; Inga Arune Blumbyte; Sarina Rudolf; Annette G Beck-Sickinger; Jolanta Malyszko; Goce Spasovski; Sol Carriazo; Davide Viggiano; Justina Kurganaite; Vaiva Sarkeviciene; Daiva Rastenyte; Andreja Figurek; Merita Rroji; Christopher Mayer; Mustapha Arici; Gianvito Martino; Gioacchino Tedeschi; Annette Bruchfeld; Belinda Spoto; Ivan Rychlik; Andrzej Wiecek; Mark Okusa; Giuseppe Remuzzi; Francesca Mallamaci
Journal:  Nephrol Dial Transplant       Date:  2021-12-28       Impact factor: 5.992

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.